Clearside Biomedical Inc (CLSD) Insider Trading
- $5,983,394.60
- $10,253,417.17
- Nov. 1, 2024
- Clay Thorp
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 1, 2024 | Insider | 36,500 | $1.00 | Buy | $36,500.00 | |
June 24, 2024 | Insider | 23,500 | $1.06 | Buy | $24,910.00 | |
May 15, 2024 | Director | 7,813 | $1.31 | Buy | $10,235.03 | |
April 17, 2024 | Director | 6,710 | $1.25 | Buy | $8,387.50 | |
March 20, 2024 | Insider | 30,000 | $1.60 | Buy | $48,000.00 | |
Feb. 7, 2024 | Major Shareholder | 444,444 | $1.35 | Buy | $599,999.40 | |
Jan. 19, 2024 | CEO | 18,000 | $1.27 | Sell | $22,860.00 | |
Jan. 19, 2024 | CFO | 12,900 | $1.28 | Sell | $16,512.00 | |
Nov. 1, 2023 | Major Shareholder | 64,366 | $0.74 | Buy | $47,630.84 | |
Oct. 30, 2023 | Major Shareholder | 600 | $0.69 | Buy | $414.00 | |
Oct. 3, 2023 | Director | 10,000 | $0.86 | Buy | $8,600.00 | |
Sept. 25, 2023 | Director | 10,000 | $0.86 | Buy | $8,600.00 | |
Jan. 20, 2023 | Insider | 13,700 | $1.47 | Sell | $20,139.00 | |
Jan. 19, 2023 | CEO | 20,030 | $1.46 | Sell | $29,243.80 | |
Jan. 19, 2023 | CFO | 14,030 | $1.50 | Sell | $21,045.00 | |
Jan. 10, 2023 | Insider | 2,170 | $1.62 | Sell | $3,515.40 | |
Dec. 21, 2022 | Director | 14,000 | $1.02 | Buy | $14,280.00 | |
Nov. 17, 2022 | Director | 30,000 | $1.33 | Buy | $39,900.00 | |
Jan. 19, 2022 | Insider | 9,050 | $2.13 | Sell | $19,276.50 | |
Jan. 19, 2022 | CFO | 8,833 | $2.09 | Sell | $18,460.97 | |
Jan. 19, 2022 | CEO | 10,800 | $2.12 | Sell | $22,896.00 | |
Jan. 11, 2022 | CEO | 5,100 | $2.46 | Sell | $12,546.00 | |
Sept. 21, 2021 | CFO | 2,800 | $6.41 | Sell | $17,948.00 | |
Sept. 21, 2021 | CEO | 3,525 | $6.46 | Sell | $22,771.50 | |
Sept. 21, 2021 | Insider | 2,560 | $6.40 | Sell | $16,384.00 | |
Sept. 1, 2021 | Major Shareholder | 213,203 | $6.89 | Sell | $1,468,968.67 | |
Aug. 30, 2021 | Major Shareholder | 99,400 | $7.06 | Sell | $701,764.00 | |
June 21, 2021 | CFO | 2,938 | $4.37 | Sell | $12,839.06 | |
June 21, 2021 | CEO | 3,707 | $4.38 | Sell | $16,236.66 | |
March 19, 2021 | CEO | 3,370 | $2.82 | Sell | $9,503.40 | |
Feb. 10, 2021 | Director | 32,873 | $4.43 | Sell | $145,627.39 | |
Jan. 6, 2021 | Major Shareholder | 350,750 | $2.85 | Buy | $999,637.50 | |
Dec. 24, 2020 | Major Shareholder | 51,195 | $1.95 | Buy | $99,830.25 | |
Dec. 2, 2020 | Major Shareholder | 53,900 | $1.95 | Buy | $105,105.00 | |
Nov. 24, 2020 | Major Shareholder | 62,000 | $1.65 | Buy | $102,300.00 | |
Nov. 16, 2020 | Major Shareholder | 62,000 | $1.69 | Buy | $104,780.00 | |
Sept. 22, 2020 | CEO | 13,411 | $1.59 | Sell | $21,323.49 | |
Aug. 18, 2020 | Director | 5,586 | $1.78 | Buy | $9,943.08 | |
Aug. 12, 2020 | Major Shareholder | 300,000 | $1.63 | Buy | $489,000.00 | |
May 20, 2020 | Director | 5,000 | $1.88 | Buy | $9,400.00 | |
May 12, 2020 | CEO | 32,150 | $1.99 | Sell | $63,978.50 | |
Nov. 12, 2019 | CFO | 7,500 | $1.14 | Buy | $8,550.00 | |
Nov. 11, 2019 | CEO | 12,000 | $1.16 | Buy | $13,920.00 | |
March 15, 2019 | CFO | 10,000 | $1.36 | Buy | $13,600.00 | |
Dec. 6, 2018 | Director | 8,000 | $1.36 | Buy | $10,880.00 | |
June 4, 2018 | Insider | 11,000 | $9.07 | Buy | $99,770.00 | |
May 18, 2018 | Director | 161,139 | $13.08 | Sell | $2,107,698.12 | |
March 23, 2018 | CFO | 500 | $11.79 | Buy | $5,895.00 | |
March 22, 2018 | Director | 7,500 | $11.89 | Buy | $89,175.00 | |
Dec. 7, 2017 | Director | 5,000 | $6.13 | Sell | $30,650.00 |
Insiders are both buying and selling Clearside Biomedical Inc stock.
The insider traders at Clearside Biomedical Inc are: Clay Thorp, Daniel H White, Bradford T Whitmore, George M Lasezkay, Charles A Deignan, Thomas Ciulla, Christy L Shaffer, Nancy J Hutson, Ngai Hang Victor Chong, Gerald D Cagle, William D Humphries, Benjamin R Yerxa, Bradford T. Whitmore, George M. Lasezkay, Venture Advisors Iii Hatteras, Venture Advisors Iv S Hatteras, and Anthony S Gibney
The most active insider trader at Clearside Biomedical Inc is Clay Thorp with 28 trades.
Clay Thorp has sold the most Clearside Biomedical Inc stock with a total value of $7,099,536.98.
Venture Advisors Iv S Hatteras has bought the most Clearside Biomedical Inc stock with a total value of $5,800,004.00.
The most recent insider trade for Clearside Biomedical Inc was on Nov. 1, 2024.
The single biggest insider buy for Clearside Biomedical Inc was from Venture Advisors Iv S Hatteras with a total value of $2,900,002.00 on June 7, 2016.
The single biggest insider sell for Clearside Biomedical Inc was from Clay Thorp with a total value of $2,107,698.12 on May 18, 2018.